Skip to content
SupplementReviewed June 2026 · v1.0

Melatonin

The Body-Clock Signal

There is high confidence that melatonin is a modest body-clock signal and not a strong sleeping pill: it is genuinely useful for timing problems such as jet lag and circadian rhythm disorders, but weak for ordinary insomnia. Confidence is moderate for specific circadian and pediatric uses, and limited for anxiety, mood, and cognition.

How confident is BioSignal?

Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.

High confidence

There is high confidence that melatonin is a modest body-clock signal and not a strong sleeping pill: it is genuinely useful for timing problems such as jet lag and circadian rhythm disorders, but weak for ordinary insomnia. Confidence is moderate for specific circadian and pediatric uses, and limited for anxiety, mood, and cognition.

Well-supported by consistent, high-quality evidence.

Biological Role

High confidence

Melatonin's role as the pineal gland's nocturnal signal, acting on MT1/MT2 receptors in the brain's master clock, is well established.

Human Evidence

Moderate confidence

Human research supports a chronobiotic (clock-shifting) effect and a small direct sleep effect, with strength varying by indication and formulation.

Supplement Benefit

Moderate confidence

Benefits are clearest for timing problems such as jet lag and circadian rhythm disorders; the effect on ordinary insomnia is small.

Broader Claims

Limited evidence

Evidence for anxiety, mood, cognition, recovery, and general health outcomes is sparse and not established.

Safety Confidence

Moderate confidence

Short-term use is generally well tolerated in adults, but long-term and pediatric data are limited and supplement quality is inconsistent.

Research Activity

High

Melatonin remains an active research area spanning circadian medicine, pediatric sleep, dosing, and supplement quality.

Where the evidence stands today

How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.

6/9

steps proven in humans

Evidence-rich

Proven at every applicable step — rare, and worth noticing.

  1. Guideline / regulatory support

    Proven

    Guidelines support melatonin for circadian rhythm disorders and specifically do NOT recommend it for chronic insomnia. It is a prescription medicine in much of Europe.

  2. Clinical outcomes

    Limited

    Supported for jet lag and circadian rhythm disorders. Weak for chronic insomnia — where sleep-onset gains are measured in minutes, not the transformation the packaging implies.

  3. Large human RCTs

    Limited

    Sparse. The trials that exist are mostly small and short.

  4. Small human outcome trials

    Proven

    Numerous, across jet lag, delayed sleep phase, and insomnia.

  5. Human safety data

    Limited

    Good in short-term use. LONG-TERM safety, and safety in children — where use has risen sharply — are not well characterised. This is a real gap, not a formality.

  6. Human biomarker / pharmacology

    Proven

    Phase shifts are measurable in humans (dim-light melatonin onset). The clock genuinely moves — which is different from being sedated.

  7. Animal

    Proven

    Substantial circadian data.

  8. Cell / in vitro

    Proven

    Receptor pharmacology well characterised.

  9. Mechanistic plausibility

    Proven

    An endogenous circadian signal — the hormone of darkness. The mechanism is a timing cue, which is the whole point and the source of the confusion.

The bottom line

What we know, what we think, what we don't know — and what would change our mind.

What We Know

Melatonin is the body's chemical night signal and acts primarily as a chronobiotic that can shift the timing of the circadian clock, with only a small direct sleep-promoting effect.

What We Think

Correctly timed, low-dose melatonin genuinely helps timing problems — jet lag, delayed sleep phase, non-24 in blind people, and select pediatric cases — but is weak for ordinary insomnia, where CBT-I is first-line.

What We Don't Know

Long-term and pediatric safety (including any effects on puberty), the best low-dose timing protocols, and whether melatonin meaningfully helps age-related sleep or non-sleep claims remain unclear.

Active Research

Research is exploring optimal low-dose timing for each circadian indication, long-term and pediatric safety, and the persistent problem of supplement content variability.

What Could Change Our Mind

Evidence of a strong dose-dependent sedative effect, or long-term pediatric safety cohorts, could expand or temper how melatonin is used and understood.

The biggest myth

Melatonin is a sleeping pill

Not establishedHigh confidence

Its dominant, best-evidenced action is shifting circadian timing, not sedation; it nudges the clock and mildly promotes sleepiness rather than knocking you out.

Ask BioSignal

Still have a question about melatonin?

Answers are retrieved from this record and the rest of the knowledge graph — never generated.

Ask about Melatonin

Why people take melatonin

Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.

Melatonin is bought as a sleeping pill, and it is not one. The interest is easy to understand — it is available without a prescription, it feels natural, and it is not a benzodiazepine — and that combination has made it the default answer for anyone lying awake. The correction this record has to make is a category error rather than a dosage one: melatonin tells your body what TIME it is, it does not make you unconscious. That single distinction explains why it works so well for jet lag and so poorly for the 3 a.m. wakefulness that most people are actually taking it for.

If you're here because…

Jump straight to the part of the evidence that answers your question.

Approval, safety and regulatory

What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.

Regulatory status

Dietary supplement in the US. A prescription medicine in much of Europe

Availability

Over-the-counter in the US; prescription-only in many other countries

Sport (WADA)

Not prohibited

Known safety profile

For most adults, sensible short-term use of melatonin is generally well tolerated and low-risk. The practical safety story is dominated by product quality, correct dosing and timing, drug interactions, and caution in children and pregnancy.

Common issues

  • Morning grogginess or next-day sleepiness (more with high doses)
  • Headache
  • Vivid dreams or nightmares
  • Transient dizziness or nausea

Use caution if

  • Children for routine use (reserve for specific disorders under clinician guidance)
  • People who are pregnant or breastfeeding (limited safety data)
  • People taking anticoagulants, antidepressants, sedatives, or other CNS depressants
  • People on blood-pressure, diabetes, or immunosuppressant medications, or with autoimmune conditions

Long-term unknowns

Long-term safety of chronic use is reasonably reassuring short-term in adults but is not well characterised over years, and pediatric long-term data — including any effects on puberty or reproductive hormones — are limited.

Limits of this evidence

A major, under-appreciated concern is supplement quality: measured content has ranged widely from label and serotonin contamination has been found in some products, which undermines both research and consumer use. Choose quality-assured, third-party-tested products and be wary of high-dose gummies and pediatric overdose risk.

Demand, separated from evidence

Every claim people make about this, counted against what the evidence actually showed.

BioSignal evaluated 11 popular claims about melatonin.

Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.

Supported by evidence
2
Mixed evidence
2
Insufficient evidence
1
Not established
6

Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.

Supported by evidence

  • Melatonin corrects jet lag
  • Melatonin helps circadian rhythm disorders

Mixed evidence

  • Melatonin helps you fall asleep
  • Children can safely take melatonin

Insufficient evidence

  • Melatonin improves recovery, cognition, or general health

Not established

  • Melatonin keeps you asleep through the night
  • More melatonin works better
  • Melatonin is a sleeping pill
  • Melatonin fixes chronic insomnia
  • Melatonin is addictive
  • Everyone should take melatonin nightly

The evidence review

Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.

What people claim

Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.

Melatonin helps you fall asleepMixedModerate confidence

It is associated with a small reduction in time to fall asleep, larger in people with delayed circadian timing than in general insomnia; it is not a powerful sleep inducer.

Melatonin keeps you asleep through the nightNot establishedModerate confidence

Direct effects on staying asleep are weak, and sleep-medicine guidance suggests against melatonin for sleep-maintenance insomnia, though prolonged-release forms aim to help.

More melatonin works betterNot establishedModerate confidence

Low, near-physiologic doses often work as well or better than high doses for circadian and onset effects, while higher doses add grogginess without proportional benefit.

Melatonin fixes chronic insomniaNot establishedHigh confidence

The American Academy of Sleep Medicine suggests clinicians not use melatonin for chronic insomnia; cognitive behavioural therapy for insomnia (CBT-I) remains first-line.

Melatonin corrects jet lagSupportedModerate confidence

A Cochrane review found melatonin effective for preventing and reducing jet lag, especially crossing multiple time zones eastward, when timed to destination bedtime.

Melatonin helps circadian rhythm disordersSupportedModerate confidence

Strategically timed melatonin is guideline-endorsed for delayed sleep-wake phase disorder and non-24 in blind adults; shift-work evidence is weaker and mixed.

Children can safely take melatoninMixedModerate confidence

Prolonged-release melatonin is supported short-term for sleep-onset problems in children with autism/neurodevelopmental disorders under guidance, but long-term safety is not fully established and product quality is a concern.

Melatonin is addictiveNot establishedModerate confidence

Melatonin is not associated with tolerance, withdrawal, or physical dependence in the manner of sedative-hypnotics; psychological reliance on a bedtime ritual is habit, not addiction.

Everyone should take melatonin nightlyNot establishedHigh confidence

Melatonin is a targeted tool for timing problems, not a general nightly supplement; routine use in people without a circadian issue lacks a rationale.

Melatonin improves recovery, cognition, or general healthInsufficient evidenceLimited evidence

Beyond sleep timing, robust evidence that melatonin improves recovery, cognition, mood, or general health is lacking; any benefit is most plausibly indirect via better-timed sleep.

Doses used in human studies

What was actually given to participants in the research. These are descriptions of studies, not recommendations.

Healthy adults (sleep onset / jet lag)

Intervention
Oral immediate-release melatonin, low dose
Dose
~0.5–1 mg
Duration
As needed; jet lag around travel
Outcome
Sleep onset; circadian phase shift
Notes
Near-physiologic dosing; timing matters more than amount

Travellers with jet lag

Intervention
Oral melatonin timed to destination bedtime
Dose
~0.5–5 mg
Duration
Days around travel
Outcome
Reduced jet-lag symptoms
Notes
Timed to destination night; well-supported use

Adults (circadian phase-shifting)

Intervention
Oral melatonin, early evening timing
Dose
~0.5–1 mg
Duration
Under guidance
Outcome
Advancing delayed sleep phase
Notes
Phase-response curve means timing is decisive

Children with ASD / neurodevelopmental disorders

Intervention
Prolonged-release melatonin (under clinician guidance)
Dose
~2–5 mg
Duration
Short-term, studied in trials
Outcome
Sleep-onset insomnia
Notes
After behavioural measures; quality-assured products

Where scientists agree — and don’t

Agreed

  • Melatonin is the circadian clock's chemical night signal and acts as a chronobiotic that can shift sleep timing.
  • Timed melatonin genuinely helps jet lag and certain circadian rhythm disorders such as delayed sleep phase and non-24 in blind adults.
  • Its direct sleep-inducing effect is small, and it is not a strong treatment for chronic insomnia.
  • Low, near-physiologic doses are often as effective as high doses, and timing matters more than quantity.

Debated

  • Whether melatonin has any meaningful role in routine insomnia.
  • The ideal dose and formulation across indications.
  • How freely melatonin should be used in children.

Unknown

  • Long-term safety of chronic use, especially in children, including any effect on puberty.
  • The best low-dose timing protocols for each circadian indication.
  • Whether melatonin meaningfully improves age-related sleep or any non-sleep outcomes.

What remains unknown

  • What is the long-term safety of chronic melatonin use, especially in children?
  • What are the optimal low-dose, correctly-timed protocols for each circadian indication?
  • Does melatonin meaningfully improve age-related sleep changes?
  • Are there any real non-sleep benefits for mood, cognition, or recovery?

Questions people actually ask

What is melatonin?

Melatonin is a hormone the brain's pineal gland releases at night to signal biological night-time. It rises in the evening, peaks overnight, and falls by morning, helping consolidate sleep and align the body to the dark period. As a supplement, it is taken to shift or reinforce this timing signal.

How does melatonin work?

Supplemental melatonin acts mainly as a chronobiotic: by acting on MT1/MT2 receptors in the brain's master clock, appropriately timed melatonin can advance or delay the circadian phase along a phase-response curve. It also mildly promotes sleepiness near bedtime, but this direct sleep effect is small compared with its clock-shifting action.

Why is timing more important than dose?

Because melatonin works along a phase-response curve, the same dose can help, do nothing, or shift the clock the wrong way depending on when it is taken. For phase-advancing night-owls, melatonin is taken in the early evening; for a mild sleep nudge, shortly before bed. Getting the time wrong can blunt or reverse the intended effect.

What forms of melatonin exist?

Immediate-release forms give a quick pulse suited to shifting timing or helping sleep onset, while prolonged-release forms release over the night and are studied for sleep maintenance and in pediatric formulations. Some regions also have prescription prolonged-release melatonin and receptor-agonist drugs, which are distinct from over-the-counter supplements.

Why does supplement quality matter so much?

Independent analysis has found over-the-counter melatonin content varying widely from label, with unlabeled serotonin present in some products. Because you often cannot trust what is in the bottle, choosing quality-assured, third-party-tested products and using accurate doses matters, especially for children. This is educational information, not a recommendation.

Practical takeaways

  • Melatonin is a body-clock signal, not a sleeping pill — timing matters more than dose.
  • It genuinely helps timing problems: jet lag, delayed sleep phase, and non-24 in blind people.
  • Its effect on ordinary insomnia is small; chronic insomnia is best treated with CBT-I, not melatonin.
  • Low doses usually suffice; higher doses add grogginess without more benefit.
  • Supplement quality is inconsistent, so quality-assured products and correct timing matter most.

How it works

The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.

Melatonin's role as the pineal gland's nocturnal signal, acting on MT1/MT2 receptors in the brain's master clock, is well established.

How we found out

  1. Discovery of the Night Signal

    Melatonin was identified as the pineal hormone released at night, establishing it as the body's internal night-time signal.

  2. Chronobiotic Era

    Research established melatonin's clock-shifting action along a phase-response curve, distinguishing timing effects from direct sedation.

  3. Clinical Guidance & Calibration

    Clinical guidelines endorsed timed melatonin for circadian rhythm disorders while advising against it as a treatment for chronic insomnia.

  4. Current Research

    Ongoing work investigates low-dose timing protocols, pediatric use, long-term safety, and the persistent problem of supplement content variability.

References

Verified sources. BioSignal does not print a citation it has not checked.

  1. 01

    Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults (AASM)

    J Clin Sleep Med 13(2):307-349 · 2017

  2. 02

    Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders (AASM, 2015 update)

    J Clin Sleep Med 11(10):1199-1236 · 2015

  3. 03

    Melatonin for the prevention and treatment of jet lag

    Cochrane Database Syst Rev (2):CD001520 · 2002

  4. 04

    Meta-analysis: melatonin for the treatment of primary sleep disorders

    PLoS One 8(5):e63773 · 2013

  5. 05

    Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content

    J Clin Sleep Med 13(2):275-281 · 2017

  6. 06

    Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder

    J Am Acad Child Adolesc Psychiatry 56(11):948-957 · 2017

Version history

  • Version 1.0

    First published Signal Record for the Alpha launch, distilled from Gold Standard Record #006. Verified references attached. Future versions will track scientific updates, evidence changes, and review history.

Continue exploring

Three places this record leads next.

All connected science (1 more)